These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 17374734)

  • 21. Association of a functional tandem repeats in the downstream of human telomerase gene and lung cancer.
    Wang L; Soria JC; Chang YS; Lee HY; Wei Q; Mao L
    Oncogene; 2003 Oct; 22(46):7123-9. PubMed ID: 14562040
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of prostacyclin synthase in carcinogenesis.
    Sasaki Y; Ochiai T; Takamura M; Kondo Y; Yokoyama C; Hara S
    Prostaglandins Other Lipid Mediat; 2017 Nov; 133():49-52. PubMed ID: 28506876
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Suppression of thymidine phosphorylase expression by promoter methylation in human cancer cells lacking enzyme activity.
    Guarcello V; Blanquicett C; Naguib FN; El Kouni MH
    Cancer Chemother Pharmacol; 2008 Jun; 62(1):85-96. PubMed ID: 17805539
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pulmonary prostacyclin synthase overexpression chemoprevents tobacco smoke lung carcinogenesis in mice.
    Keith RL; Miller YE; Hudish TM; Girod CE; Sotto-Santiago S; Franklin WA; Nemenoff RA; March TH; Nana-Sinkam SP; Geraci MW
    Cancer Res; 2004 Aug; 64(16):5897-904. PubMed ID: 15313935
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epigenetic inactivation of Homeobox A5 gene in nonsmall cell lung cancer and its relationship with clinicopathological features.
    Kim DS; Kim MJ; Lee JY; Lee SM; Choi JY; Yoon GS; Na YK; Hong HS; Kim SG; Choi JE; Lee SY; Park JY
    Mol Carcinog; 2009 Dec; 48(12):1109-15. PubMed ID: 19554572
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CMTM5 exhibits tumor suppressor activities and is frequently silenced by methylation in carcinoma cell lines.
    Shao L; Cui Y; Li H; Liu Y; Zhao H; Wang Y; Zhang Y; Ng KM; Han W; Ma D; Tao Q
    Clin Cancer Res; 2007 Oct; 13(19):5756-62. PubMed ID: 17908965
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Promoter-hypermethylation associated defective expression of E-cadherin in primary non-small cell lung cancer.
    Wang G; Hu X; Lu C; Su C; Luo S; Luo ZW
    Lung Cancer; 2008 Nov; 62(2):162-72. PubMed ID: 18468719
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Promoter demethylation of WIF-1 by epigallocatechin-3-gallate in lung cancer cells.
    Gao Z; Xu Z; Hung MS; Lin YC; Wang T; Gong M; Zhi X; Jablon DM; You L
    Anticancer Res; 2009 Jun; 29(6):2025-30. PubMed ID: 19528461
    [TBL] [Abstract][Full Text] [Related]  

  • 29. VEGF expression is augmented by hypoxia‑induced PGIS in human fibroblasts.
    Wang J; Ikeda R; Che XF; Ooyama A; Yamamoto M; Furukawa T; Hasui K; Zheng CL; Tajitsu Y; Oka T; Tabata S; Nishizawa Y; Eizuru Y; Akiyama S
    Int J Oncol; 2013 Sep; 43(3):746-54. PubMed ID: 23807031
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Down-regulation of DLX3 expression in MLL-AF4 childhood lymphoblastic leukemias is mediated by promoter region hypermethylation.
    Campo Dell'Orto M; Banelli B; Giarin E; Accordi B; Trentin L; Romani M; te Kronnie G; Basso G
    Oncol Rep; 2007 Aug; 18(2):417-23. PubMed ID: 17611665
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MUC1 expression is regulated by DNA methylation and histone H3 lysine 9 modification in cancer cells.
    Yamada N; Nishida Y; Tsutsumida H; Hamada T; Goto M; Higashi M; Nomoto M; Yonezawa S
    Cancer Res; 2008 Apr; 68(8):2708-16. PubMed ID: 18413738
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Specific components of prostanoid-signaling pathways are present in non-small cell lung cancer cells.
    Kreutzer M; Fauti T; Kaddatz K; Seifart C; Neubauer A; Schweer H; Kömhoff M; Müller-Brüsselbach S; Müller R
    Oncol Rep; 2007 Aug; 18(2):497-501. PubMed ID: 17611676
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Promoter analysis of epigenetically controlled genes in bladder cancer.
    Veerla S; Panagopoulos I; Jin Y; Lindgren D; Höglund M
    Genes Chromosomes Cancer; 2008 May; 47(5):368-78. PubMed ID: 18196590
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The tumor suppressor gene hypermethylated in cancer 1 is transcriptionally regulated by E2F1.
    Jenal M; Trinh E; Britschgi C; Britschgi A; Roh V; Vorburger SA; Tobler A; Leprince D; Fey MF; Helin K; Tschan MP
    Mol Cancer Res; 2009 Jun; 7(6):916-22. PubMed ID: 19491197
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Downregulation of stathmin expression is mediated directly by Egr1 and associated with p53 activity in lung cancer cell line A549.
    Fang L; Min L; Lin Y; Ping G; Rui W; Ying Z; Xi W; Ting H; Li L; Ke D; Jihong R; Huizhong Z
    Cell Signal; 2010 Jan; 22(1):166-73. PubMed ID: 19786090
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epigenetic regulation of the expression of the novel stem cell marker CDCP1 in cancer cells.
    Ikeda JI; Morii E; Kimura H; Tomita Y; Takakuwa T; Hasegawa JI; Kim YK; Miyoshi Y; Noguchi S; Nishida T; Aozasa K
    J Pathol; 2006 Sep; 210(1):75-84. PubMed ID: 16823897
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A variant in the CHEK2 promoter at a methylation site relieves transcriptional repression and confers reduced risk of lung cancer.
    Zhang S; Lu J; Zhao X; Wu W; Wang H; Lu J; Wu Q; Chen X; Fan W; Chen H; Wang F; Hu Z; Jin L; Wei Q; Shen H; Huang W; Lu D
    Carcinogenesis; 2010 Jul; 31(7):1251-8. PubMed ID: 20462940
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phospholipase C delta 1 is a novel 3p22.3 tumor suppressor involved in cytoskeleton organization, with its epigenetic silencing correlated with high-stage gastric cancer.
    Hu XT; Zhang FB; Fan YC; Shu XS; Wong AH; Zhou W; Shi QL; Tang HM; Fu L; Guan XY; Rha SY; Tao Q; He C
    Oncogene; 2009 Jul; 28(26):2466-75. PubMed ID: 19448674
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic-deletion of Cyclooxygenase-2 Downstream Prostacyclin Synthase Suppresses Inflammatory Reactions but Facilitates Carcinogenesis, unlike Deletion of Microsomal Prostaglandin E Synthase-1.
    Sasaki Y; Kamiyama S; Kamiyama A; Matsumoto K; Akatsu M; Nakatani Y; Kuwata H; Ishikawa Y; Ishii T; Yokoyama C; Hara S
    Sci Rep; 2015 Nov; 5():17376. PubMed ID: 26611322
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of RUNX3 gene, methylation status and clinicopathological significance in breast cancer and breast cancer cell lines.
    Jiang Y; Tong D; Lou G; Zhang Y; Geng J
    Pathobiology; 2008; 75(4):244-51. PubMed ID: 18580070
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.